Status:
UNKNOWN
Percutaneous Mitral Valve Repair in Cardiogenic Shock: Mitra-Shock Study
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Mitral Regurgitation Functional
Eligibility:
All Genders
Brief Summary
Cardiogenic shock (CS) is a medical emergency and a frequent cause of death. CS can be complicated and/or precipitated by mitral regurgitation (MR). The efficacy of percutaneous treatment of MR in pat...
Eligibility Criteria
Inclusion
- older than 18 years old
Exclusion
- multiorgan failure,
- VA-ECMO,
- inadequate peripheral access because of vascular disease,
- not suitable mitral valve anatomy.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04399499
Start Date
June 1 2020
End Date
July 1 2020
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCSS San Raffaele
Milan, Italy